Open‐label pilot study of tofacitinib 2% for the treatment of refractory vitiligo

British Journal of DermatologyVolume 182, Issue 4 p. 1047-1049 Research letter Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo P. Mobasher, orcid.org/0000-0002-8737-3373 University of California, Irvine, Department of Dermatology, Irvine, CA, U.S.A.Search for more papers by this authorR. Guerra, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorS.J. Li, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorJ. Frangos, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorA.K. Ganesan, University of California, Irvine, Department of Dermatology, Irvine, CA, U.S.A.Search for more papers by this authorV. Huang, Corresponding Author vtrhuang@ucdavis.edu orcid.org/0000-0001-7014-8084 Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A. University of California, Davis, Department of Dermatology, Sacramento, CA, U.S.A. Correspondence: Victor Huang. E-mail: vtrhuang@ucdavis.eduSearch for more papers by this author P. Mobasher, orcid.org/0000-0002-8737-3373 University of California, Irvine, Department of Dermatology, Irvine, CA, U.S.A.Search for more papers by this authorR. Guerra, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorS.J. Li, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorJ. Frangos, Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A.Search for more papers by this authorA.K. Ganesan, University of California, Irvine, Department of Dermatology, Irvine, CA, U.S.A.Search for more papers by this authorV. Huang, Corresponding Author vtrhuang@ucdavis.edu orcid.org/0000-0001-7014-8084 Brigham and Women's Hospital, Department of Dermatology, Boston, MA, U.S.A. University of California, Davis, Department of Dermatology, Sacramento, CA, U.S.A. Correspondence: Victor Huang. E-mail: vtrhuang@ucdavis.eduSearch for more papers by this author First published: 12 October 2019 https://doi.org/10.1111/bjd.18606Citations: 7 Funding sources: National Institutes of Health grant 1R21AR073408-01 (to P.M. and A.K.G.) Conflicts of interest: none to declare. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume182, Issue4April 2020Pages 1047-1049 RelatedInformation